Table 7.
Correlation analysis in recurrent ovarian carcinoma
CXCR4 TIC | CXCR4 tumor | pCXCR4 TIC | pCXCR4 tumor | ||
---|---|---|---|---|---|
CXCR4 TIC | rs | 1.000 | |||
p | |||||
CXCR4 tumor | rs | 0.162 | 1.000 | ||
p | 0.299 | ||||
pCXCR4 TIC | rs | 0.394 | 0.129 | 1.000 | |
p | 0.019 | 0.461 | |||
pCXCR4 tumor | rs | 0.035 | 0.507 | 0.236 | 1.000 |
p | 0.842 | 0.002 | 0.172 | ||
MPO | rs | 0.577 | 0.072 | 0.162 | 0.146 |
p | <0.001 | 0.648 | 0.354 | 0.402 | |
IL-17 | rs | 0.260 | 0.148 | -0.074 | 0.096 |
p | 0.092 | 0.344 | 0.674 | 0.583 | |
FOXP3 | rs | 0.220 | 0.160 | -0.210 | 0.057 |
p | 0.203 | 0.358 | 0.266 | 0.764 | |
OX40 TIC | rs | 0.166 | 0.441 | 0.159 | 0.338 |
p | 0.286 | 0.003 | 0.360 | 0.047 | |
OX40 tumor | rs | 0.183 | 0.576 | 0.044 | 0.376 |
p | 0.241 | <0.001 | 0.800 | 0.026 | |
CD66b | rs | 0.414 | 0.015 | 0.138 | 0.200 |
p | 0.006 | 0.926 | 0.430 | 0.249 |
Correlation analysis of CXCR4 TIC, CXCR4 tumor expression, pCXCR4 TIC, pCXCR4 tumor expression, MPO, IL-17, FOXP3, OX40 TIC, OX40 tumor expression and CD66b in recurrent ovarian carcinoma